Fenfluramine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Fenfluramine. Educational only — not medical advice.
Labeled uses
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older.
Source: FDA labeling via NIH DailyMed (set e88f360e…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.